Impact of Radical Treatment on Prostate Cancer Survival
Author Information
Author(s): C Parker, D Muston, J Melia, S Moss, D Dearnaley
Primary Institution: Institute of Cancer Research and Royal Marsden NHS Foundation Trust
Hypothesis
What is the effect of radical treatment on overall survival in screen-detected prostate cancer?
Conclusion
The study suggests that the absolute survival benefit of radical treatment is greater in men with high-grade prostate cancer.
Supporting Evidence
- The model predicts that the absolute survival benefit of radical treatment is greater in higher-grade disease.
- For men aged 55-59 years at diagnosis, the absolute 15-year survival benefit from curative treatment is 0%, 12%, and 26% for Gleason scores <7, 7, and >7, respectively.
- The study indicates that current clinical practice may not align with the findings regarding treatment benefits.
Takeaway
This study looks at how treating prostate cancer found by screening affects survival, showing that men with more serious cancer benefit more from treatment.
Methodology
A competing-risks hazard model was developed to estimate the natural history of screen-detected prostate cancer and the impact of radical treatment on overall survival.
Potential Biases
The study relies on historical data which may not reflect current clinical practices.
Limitations
The model's accuracy depends on the validity of the underlying assumptions and may not be generalizable.
Participant Demographics
Men aged 55-74 years diagnosed with localized prostate cancer.
Statistical Information
P-Value
0.01
Confidence Interval
95% CI: 0.36–0.88
Statistical Significance
p=0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website